Cagrilintide 5mg — Long-Acting Amylin Analogue Research Peptide

Cagrilintide 5mg is a research-grade, long-acting amylin analogue supplied as a lyophilised powder, sealed and independently assayed to ≥99% purity. Each vial contains 5mg of Cagrilintide for use in laboratory research.

Cagrilintide is a synthetic analogue of the hormone amylin and is frequently studied alongside GLP-1 receptor agonists in combined metabolic-research models, making it a popular addition to peptide research programmes.

key specifications

Compound: Cagrilintide (long-acting amylin analogue)
Strength: 5mg per vial
CAS number: 1949837-12-0
Molar mass: ~3754 g/mol
Purity: ≥99% (HPLC, third-party verified)
Form: Lyophilised powder · single sealed vial

Commonly researched with

Researchers often study in parallel with our Semaglutide and wider GLP-1 research range when modelling combined receptor pathways.

Purity & third-party testing

Every batch of it independently analysed by Janoshik Analytical, with a Certificate of Analysis confirming identity and ≥99% purity available on request.

Storage & handling

Store sealed at -20°C, protected from light. After reconstitution with bacteriostatic water, refrigerate and use within your protocol’s window under good laboratory practice.

Cagrilintide 5mg — frequently asked questions

What is Cagrilintide 5mg?

It is a research peptide containing 5mg of Cagrilintide, a long-acting amylin analogue, supplied as a lyophilised powder for laboratory research use only.

Is third-party tested?

Yes — every batch is independently tested by Janoshik Analytical to ≥99% purity, with a COA available on request.

How is Cagrilintide 5mg supplied?

As a freeze-dried powder in a single sealed vial, despatched same-day from the UK via Royal Mail Tracked 24.

Do you ship across the UK?

Yes — same-day despatch and fully tracked delivery on all in-stock research peptides.

Compliance: This product is sold strictly for laboratory and research use only. It is not a medicinal product, is not for human or veterinary consumption, and is not intended to diagnose, treat, cure or prevent any disease. For guidance on the regulation of research compounds in the UK, see the MHRA.